Abstract
Purpose: To define unmet needs in ophthalmology that can realistically be addressed in the next 5 years (2019–2025) and describe potential avenues for research to address these challenges. Methods: Outcomes of a consensus process within the European Vision institute (Brussels) are outlined. Disease areas that are discussed comprise glaucoma, retinal dystrophies, diabetic retinopathy, dry eye disease, corneal diseases, cataract and refractive surgery. Results: Unmet needs in the mentioned disease areas are discussed and realistically achievable research projects outlined. Conclusions: Considerable progress can be made in the ophthalmic field and patient-relevant outcomes in the near future.
References
1.
Scott
AW
, Bressler
NM
, Ffolkes
S
, Wittenborn
JS
, Jorkasky
J
. Public Attitudes About Eye and Vision Health
. JAMA Ophthalmol
. 2016
Oct
;134
(10
):1111
–8
.
[PubMed]
2168-61652.
Kass
MA
, Heuer
DK
, Higginbotham
EJ
, Johnson
CA
, Keltner
JL
, Miller
JP
, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
. Arch Ophthalmol
. 2002
Jun
;120
(6
):701
–13
.
[PubMed]
0003-99503.
Collaborative Normal-Tension Glaucoma Study Group
. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma
. Am J Ophthalmol
. 1998
Oct
;126
(4
):498
–505
.
[PubMed]
0002-93944.
Weinreb
RN
, Kaufman
PL
. Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function
. Invest Ophthalmol Vis Sci
. 2011
Oct
;52
(11
):7842
–51
.
[PubMed]
0146-04045.
Kuang
TM
, Zhang
C
, Zangwill
LM
, Weinreb
RN
, Medeiros
FA
. Estimating Lead Time Gained by Optical Coherence Tomography in Detecting Glaucoma before Development of Visual Field Defects
. Ophthalmology
. 2015
Oct
;122
(10
):2002
–9
.
[PubMed]
0161-64206.
Yu
M
, Lin
C
, Weinreb
RN
, Lai
G
, Chiu
V
, Leung
CK
. Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study
. Ophthalmology
. 2016
Jun
;123
(6
):1201
–10
.
[PubMed]
0161-64207.
Yap
TE
, Donna
P
, Almonte
MT
, et al. Real-Time Imaging of Retinal Ganglion Cell Apoptosis.
Cells 2018
; 7 2018/06/20. DOI: .8.
Rossi
EA
, Granger
CE
, Sharma
R
, Yang
Q
, Saito
K
, Schwarz
C
, et al. Imaging individual neurons in the retinal ganglion cell layer of the living eye
. Proc Natl Acad Sci USA
. 2017
Jan
;114
(3
):586
–91
.
[PubMed]
0027-84249.
Jonnal
RS
, Kocaoglu
OP
, Zawadzki
RJ
, et al. A Review of Adaptive Optics Optical Coherence Tomography: Technical Advances, Scientific Applications, and the Future. Invest Ophthalmol Vis Sci 2016
; 57: OCT51-68. 2016/07/15. DOI: .10.
De Moraes
CG
, Hood
DC
, Thenappan
A
, Girkin
CA
, Medeiros
FA
, Weinreb
RN
, et al. 24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma
. Ophthalmology
. 2017
Oct
;124
(10
):1449
–56
.
[PubMed]
0161-642011.
Kim
YK
, Ha
A
, Na
KI
, Kim
HJ
, Jeoung
JW
, Park
KH
. Temporal Relation between Macular Ganglion Cell-Inner Plexiform Layer Loss and Peripapillary Retinal Nerve Fiber Layer Loss in Glaucoma
. Ophthalmology
. 2017
Jul
;124
(7
):1056
–64
.
[PubMed]
0161-642012.
den Haan
J
, Verbraak
FD
, Visser
PJ
, Bouwman
FH
. Retinal thickness in Alzheimer’s disease: A systematic review and meta-analysis
. Alzheimers Dement (Amst)
. 2017
Jan
;6
(6
):162
–70
.
[PubMed]
2352-872913.
Yu
JG
, Feng
YF
, Xiang
Y
, et al. Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One 2014
; 9: e85718. 2014/01/28. DOI: .14.
Kim
JH
, Caprioli
J
. Intraocular Pressure Fluctuation: Is It Important?
J Ophthalmic Vis Res
. 2018
Apr-Jun
;13
(2
):170
–4
.
[PubMed]
2008-201015.
Tarkkanen
A
, Leikola
J
. Postural variations of the intraocular pressure as measured with the Mackay-Marg tonometer
. Acta Ophthalmol (Copenh)
. 1967
;45
(4
):569
–75
.
[PubMed]
0001-639X16.
Qureshi
IA
. Effects of mild, moderate and severe exercise on intraocular pressure of sedentary subjects
. Ann Hum Biol
. 1995
Nov-Dec
;22
(6
):545
–53
.
[PubMed]
0301-446017.
Ittoop
SM
, SooHoo
JR
, Seibold
LK
, Mansouri
K
, Kahook
MY
. Systematic Review of Current Devices for 24-h Intraocular Pressure Monitoring
. Adv Ther
. 2016
Oct
;33
(10
):1679
–90
.
[PubMed]
0741-238X18.
Pillunat
LE
, Erb
C
, Jünemann
AG
, Kimmich
F
. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents
. Clin Ophthalmol
. 2017
Aug
;11
(11
):1583
–600
.
[PubMed]
1177-546719.
Resende
AF
, Patel
NS
, Waisbourd
M
, et al. iStent(R) Trabecular Microbypass Stent: An Update. J Ophthalmol 2016; 2016
: 2731856. 2016/07/15. DOI: .20.
Vold
S
, Ahmed
II
, Craven
ER
, Mattox
C
, Stamper
R
, Packer
M
, et al.; CyPass Study Group
. Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
. Ophthalmology
. 2016
Oct
;123
(10
):2103
–12
.
[PubMed]
0161-642021.
Scholl
HP
, Strauss
RW
, Singh
MS
, Dalkara
D
, Roska
B
, Picaud
S
, et al. Emerging therapies for inherited retinal degeneration
. Sci Transl Med
. 2016
Dec
;8
(368
):368rv6
.
[PubMed]
1946-623422.
Liew
G
, Michaelides
M
, Bunce
C
. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010
. BMJ Open
. 2014
Feb
;4
(2
):e004015
.
[PubMed]
2044-605523.
Duncan
, et al. Recommendations on Clinical Assessment of Patients with Inherited Retinal Degenerations – 2016. Available at: https://www.aao.org/clinical-statement/recommendations-on-clinical-assessment-of-patients#Authors. Accessed November 17, 2018.24.
25.
RetNet
. Available at: https://sph.uth.edu/retnet/. Accessed April 26, 2019.26.
Consugar
MB
, Navarro-Gomez
D
, Place
EM
, Bujakowska
KM
, Sousa
ME
, Fonseca-Kelly
ZD
, et al. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing
. Genet Med
. 2015
Apr
;17
(4
):253
–61
.
[PubMed]
1098-360027.
Duncan
JL
, Pierce
EA
, Laster
AM
, Daiger
SP
, Birch
DG
, Ash
JD
, et al.; and the Foundation Fighting Blindness Scientific Advisory Board
. Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps
. Transl Vis Sci Technol
. 2018
Jul
;7
(4
):6
.
[PubMed]
2164-259128.
Russell
S
, Bennett
J
, Wellman
JA
, Chung
DC
, Yu
ZF
, Tillman
A
, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
. Lancet
. 2017
Aug
;390
(10097
):849
–60
.
[PubMed]
0140-673629.
Azeredo da Silveira
R
, Roska
B
. Cell types, circuits, computation
. Curr Opin Neurobiol
. 2011
Oct
;21
(5
):664
–71
.
[PubMed]
0959-438830.
Juettner
, et al. Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates, and humans
. [online]
. bioRxiv
. 2018
.31.
Strauss
RW
, Ho
A
, Muñoz
B
, Cideciyan
AV
, Sahel
JA
, Sunness
JS
, et al.; Progression of Stargardt Disease Study Group
. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1
. Ophthalmology
. 2016
Apr
;123
(4
):817
–28
.
[PubMed]
0161-642032.
Kong
X
, Fujinami
K
, Strauss
RW
, Munoz
B
, West
SK
, Cideciyan
AV
, et al.; ProgStar Study Group
. Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10
. JAMA Ophthalmol
. 2018
Aug
;136
(8
):920
–8
.
[PubMed]
2168-616533.
International Diabetes Federeation
(Diabetes Atlas
ID
, editor). 2013
. 6th ed. Brussels, Belgium
: International Diabetes Federation
; 2013
.[Internet
], Available from www.idf.org/diabetesatlas34.
Elman
MJ
, Aiello
LP
, Beck
RW
, Bressler
NM
, Bressler
SB
, Edwards
AR
, et al.; Diabetic Retinopathy Clinical Research Network
. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
. Ophthalmology
. 2010
Jun
;117
(6
):1064
–1077.e35
.
[PubMed]
0161-642035.
Mitchell
P
, Bandello
F
, Schmidt-Erfurth
U
, Lang
GE
, Massin
P
, Schlingemann
RO
, et al.; RESTORE study group
. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema
. Ophthalmology
. 2011
Apr
;118
(4
):615
–25
.
[PubMed]
0161-642036.
Wells
JA
, Glassman
AR
, Ayala
AR
, Jampol
LM
, Aiello
LP
, Antoszyk
AN
, et al.; Diabetic Retinopathy Clinical Research Network
. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema
. N Engl J Med
. 2015
Mar
;372
(13
):1193
–203
.
[PubMed]
0028-479337.
Figueira
J
, Silva
R
, Henriques
J
, Caldeira Rosa
P
, Laíns
I
, Melo
P
, et al. Ranibizumab for High-Risk Proliferative Diabetic Retinopathy: An Exploratory Randomized Controlled Trial
. Ophthalmologica
. 2016
;235
(1
):34
–41
.
[PubMed]
0030-375538.
Cunha-Vaz
J
, Bernardes
R
. Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes
. Prog Retin Eye Res
. 2005
May
;24
(3
):355
–77
.
[PubMed]
1350-946239.
Nunes
S
, Ribeiro
L
, Lobo
C
, Cunha-Vaz
J
. Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema
. Invest Ophthalmol Vis Sci
. 2013
Jul
;54
(7
):4595
–604
.
[PubMed]
0146-040440.
Ribeiro
ML
, Nunes
SG
, Cunha-Vaz
JG
. Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy
. Diabetes Care
. 2013
May
;36
(5
):1254
–9
.
[PubMed]
0149-599241.
Cunha-Vaz
J
, Ribeiro
L
, Lobo
C
. Phenotypes and biomarkers of diabetic retinopathy
. Prog Retin Eye Res
. 2014
Jul
;41
:90
–111
.
[PubMed]
1350-946242.
Marques
IP
, Alves
D
, Santos
T
, Mendes
L
, Santos
AR
, Lobo
C
, et al. Multimodal Imaging of the Initial Stages of Diabetic Retinopathy. Different Disease Pathways in Different Patients
. Diabetes
. 2018
Dec
;•••
:db181077
.
[PubMed]
0012-179743.
Cunha-Vaz
J
, Santos
T
, Ribeiro
L
, Alves
D
, Marques
I
, Goldberg
M
. OCT-leakage: A new method to identify and locate abnormal fluid accumulation in diabetic retinal edema
. Invest Ophthalmol Vis Sci
. 2016
Dec
;57
(15
):6776
–83
.
[PubMed]
0146-040444.
Cunha-Vaz
J
, Santos
T
, Alves
D
, Marques
I
, Neves
C
, Soares
M
, et al. Agreement between OCT Leakage and Fluorescein Angiography to Identify Sites of Alteration of the Blood-Retinal Barrier in Diabetes
. Ophthalmol Retina
. 2017
Sep - Oct
;1
(5
):395
–403
.
[PubMed]
2468-721945.
Santos
AR
, Alves
D
, Santos
T
, Figueira
J
, Silva
R
, Cunha-Vaz
JG
. Measurements of Retinal Fluid by OCT Leakage in Diabetic Macular Edema: A Biomarker of Visual Acuity Response to Treatment
. Retina
. 2019
Jan
;39
(1
):52
–60
.
[PubMed]
0275-004X46.
Santos
AR
, Ribeiro
L
, Bandello
F
, Lattanzio
R
, Egan
C
, Frydkjaer-Olsen
U
, et al.; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)
. Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR project
. Diabetes
. 2017
Sep
;66
(9
):2503
–10
.
[PubMed]
0012-179747.
Yoshimura
T
, Sonoda
KH
, Sugahara
M
, Mochizuki
Y
, Enaida
H
, Oshima
Y
, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases
. PLoS One
. 2009
Dec
;4
(12
):e8158
.
[PubMed]
1932-620348.
Srividya
G
, Jain
M
, Mahalakshmi
K
, Gayathri
S
, Raman
R
, Angayarkanni
N
. A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema
. Eye (Lond)
. 2018
Apr
;32
(4
):820
–9
.
[PubMed]
0950-222X49.
Oh
IK
, Kim
SW
, Oh
J
, Lee
TS
, Huh
K
. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy
. Curr Eye Res
. 2010
Dec
;35
(12
):1116
–27
.
[PubMed]
0271-368350.
Lee
WJ
, Kang
MH
, Seong
M
, Cho
HY
. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion
. Br J Ophthalmol
. 2012
Nov
;96
(11
):1426
–30
.
[PubMed]
0007-116151.
Dong
N
, Xu
B
, Wang
B
, Chu
L
. Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy
. Mol Vis
. 2013
Aug
;19
:1734
–46
.
[PubMed]
1090-053552.
Craig
JP
, Nelson
JD
, Azar
DT
, Belmonte
C
, Bron
AJ
, Chauhan
SK
, et al. TFOS DEWS II Report Executive Summary
. Ocul Surf
. 2017
Oct
;15
(4
):802
–12
.
[PubMed]
1542-012453.
Changing Indications in Penetrating Keratoplasty
. A Systematic Review of 34 Years of Global Reporting. Matthaei M, Sandhaeger H, Hermel M, Adler W, Jun AS, Cursiefen C, Heindl LM
. Transplantation
. 2017
Jun
;101
(6
):1387
–99
.
[PubMed]
0041-133754.
Hos
D
, Matthaei
M
, Bock
F
, Maruyama
K
, Notara
M
, Clahsen
T
, Hou
Y
, Le
VNH
, Salabarria
AC
, Horstmann
J
, Bachmann
BO
, Cursiefen
C
. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. PRER 2019
Jul 3. pii: S1350-946255.
Hos
D
, Tuac
O
, Schaub
F
, Stanzel
TP
, Schrittenlocher
S
, Hellmich
M
, et al. Incidence and Clinical Course of Immune Reactions after Descemet Membrane Endothelial Keratoplasty: Retrospective Analysis of 1000 Consecutive Eyes
. Ophthalmology
. 2017
Apr
;124
(4
):512
–8
.
[PubMed]
0161-642056.
Bock
F
, Maruyama
K
, Regenfuss
B
, Hos
D
, Steven
P
, Heindl
LM
, et al. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Bock F, Maruyama K, Regenfuss B, Hos D, Steven P, Heindl LM, Cursiefen C
. Prog Retin Eye Res
. 2013
May
;34
:89
–124
. 1350-946257.
Dietrich
T
, Bock
F
, Yuen
D
, Hos
D
, Bachmann
BO
, Zahn
G
, et al. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation
. J Immunol
. 2010
Jan
;184
(2
):535
–9
.
[PubMed]
0022-176758.
Cursiefen
C
, Colin
J
, Dana
R
, Diaz-Llopis
M
, Faraj
LA
, Garcia-Delpech
S
, et al. Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable
. Br J Ophthalmol
. 2012
Jan
;96
(1
):3
–9
.
[PubMed]
0007-116159.
Cursiefen
C
, Viaud
E
, Bock
F
, Geudelin
B
, Ferry
A
, Kadlecová
P
, et al. Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study
. Ophthalmology
. 2014
Sep
;121
(9
):1683
–92
.
[PubMed]
0161-642060.
IC3D classification of corneal dystrophies--edition 2. Weiss JS, Møller HU, Aldave AJ, Seitz B, Bredrup C, Kivelä T, Munier FL, Rapuano CJ, Nischal KK, Kim EK, Sutphin J, Busin M, Labbé A, Kenyon KR, Kinoshita S, Lisch W. Cornea.
2015
Feb;34(2):117-5961.
Ophthalmologe.
2014
Nov;111(11):1027-32. doi: . [Decellularized collagen matrix from tilapia fish scales for corneal reconstruction (BioCornea)]. [Article in German] Hos D1, van Essen TH, Bock F, Chou CH, Pan HA, Lin CC, Huang MC, Chen SC, Cursiefen C, Jager MJ.62.
Phase II Randomized
. Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis. Bonini S, Lambiase A, Rama P, Sinigaglia F, Allegretti M, Chao W, Mantelli F; REPARO Study Group
. Ophthalmology
. 2018
Sep
;125
(9
):1332
–43
.
[PubMed]
0161-642063.
Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency
. Hos D, Bukowiecki A, Horstmann J, Bock F, Bucher F, Heindl LM, Siebelmann S, Steven P, Dana R, Eming SA, Cursiefen C
. Sci Rep
. 2017
Aug
;7
(1
):7227
.
[PubMed]
2045-232264.
Rama
P
, Matuska
S
, Paganoni
G
, Spinelli
A
, De Luca
M
, Pellegrini
G
. Limbal stem-cell therapy and long-term corneal regeneration
. N Engl J Med
. 2010
Jul
;363
(2
):147
–55
.
[PubMed]
0028-479365.
Notara
M
, Lentzsch
A
, Coroneo
M
, Cursiefen
C
. The Role of Limbal Epithelial Stem Cells in Regulating Corneal (Lymph)angiogenic Privilege and the Micromilieu of the Limbal Niche following UV Exposure
. Stem Cells Int
. 2018
May
;2018
:8620172
.
[PubMed]
1687-967866.
Notara
M
, Behboudifard
S
, Kluth
MA
, Maßlo
C
, Ganss
C
, Frank
MH
, et al. UV light-blocking contact lenses protect against short-term UVB-induced limbal stem cell niche damage and inflammation
. Sci Rep
. 2018
Aug
;8
(1
):12564
.
[PubMed]
2045-232267.
Schlereth
SL
, Iden
S
, Mescher
M
, Ksander
BR
, Bosch
JJ
, Cursiefen
C
, et al. A Novel Model of Metastatic Conjunctival Melanoma in Immune-Competent Mice
. Invest Ophthalmol Vis Sci
. 2015
Sep
;56
(10
):5965
–73
.
[PubMed]
0146-040468.
Siebelmann
S
, Horstmann
J
, Scholz
P
, Bachmann
B
, Matthaei
M
, Hermann
M
, et al. Intraoperative changes in corneal structure during excimer laser phototherapeutic keratectomy (PTK) assessed by intraoperative optical coherence tomography
. Graefes Arch Clin Exp Ophthalmol
. 2018
Mar
;256
(3
):575
–81
.
[PubMed]
0721-832X© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
